Healthcare -
Biotechnology - NASDAQ - US
$ 34.055
1.23 %
$ 14.8 B
Market Cap
17.83
P/E
RPRX - CASH FROM INVESTING ACTIVITIES
Cash from Investing Activities RPRX - Royalty Pharma plc
-2.68 B
LAST VALUE
-61.29%
2 YEAR CAGR
-4.82%
5 YEAR CAGR
0.00%
10 YEAR CAGR